An Open-Label, Safety and Tolerability Study of Chronic Intermittent Use of Diazepam Nasal Spray.

NCT02316847 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
126
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Acorda Therapeutics